Related references
Note: Only part of the references are listed.Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction A Randomized, Controlled Trial
Are Annesonn Kalstad et al.
CIRCULATION (2021)
Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography
Suvasini Lakshmanan et al.
CARDIOVASCULAR RESEARCH (2020)
Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence
JoAnn E. Manson et al.
CIRCULATION RESEARCH (2020)
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
R. Preston Mason et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Icosapent Ethyl: Niche Drug or for the Masses?
Najdat Bazarbashi et al.
CURRENT CARDIOLOGY REPORTS (2020)
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial
Matthew J. Budoff et al.
EUROPEAN HEART JOURNAL (2020)
Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies
Brian Olshansky et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2020)
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol
Gregory A. Nichols et al.
DIABETES OBESITY & METABOLISM (2019)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients
Peter P. Toth et al.
MAYO CLINIC PROCEEDINGS (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid
Samuel C. R. Sherratt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin
R. Preston Mason et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction
Samuel C. R. Sherratt et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2018)
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
Om P. Ganda et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
Anum Saeed et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil
K. C. Maki et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2017)
Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study
Kazumasa Nosaka et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins
Tetsu Watanabe et al.
JOURNAL OF CARDIOLOGY (2017)
Potential benefits of eicosapentaenoic acid on atherosclerotic plaques
J. R. Nelson et al.
VASCULAR PHARMACOLOGY (2017)
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies
Christie M. Ballantyne et al.
ATHEROSCLEROSIS (2016)
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis
Kiran Musunuru et al.
CIRCULATION RESEARCH (2016)
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry
Robert Klempfner et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2016)
Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents
R. Preston Mason et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies
Christie M. Ballantyne et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry
Robert Klempfner et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2016)
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Peter P. Toth
VASCULAR HEALTH AND RISK MANAGEMENT (2016)
Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis
Kenneth M. Borow et al.
ATHEROSCLEROSIS (2015)
Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results from a randomized controlled feeding trial
Kevin C. Maki et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Triglycerides on the rise: should we swap seats on the seesaw?
Peter Libby
EUROPEAN HEART JOURNAL (2015)
Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma
Ryo Nishio et al.
ATHEROSCLEROSIS (2014)
Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
Mortality risk of triglyceride levels in patients with coronary artery disease
Takatoshi Kasai et al.
HEART (2013)
Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia
Noriko Satoh-Asahara et al.
DIABETES CARE (2012)
Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular function
Junko Sasaki et al.
ENDOCRINE JOURNAL (2012)
Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
Michael Miller et al.
CIRCULATION (2011)
High Levels of Remnant Lipoprotein Cholesterol Is a Risk Factor for Large Artery Atherosclerotic Stroke
Jeong-Yeon Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2011)
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability
Abbie L. Cawood et al.
ATHEROSCLEROSIS (2010)
Blood Eicosapentaenoic Acid and Docosahexaenoic Acid as Predictors of All-Cause Mortality in Patients With Acute Myocardial Infarction - Data From Infarction Prognosis Study (IPS) Registry -
Sang-Hak Lee et al.
CIRCULATION JOURNAL (2009)
Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
Jacob J. Freiberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
Michael Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Sandeep Bansal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
Nadeem Sarwar et al.
CIRCULATION (2007)
Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome
Noriko Satoh et al.
DIABETES CARE (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart Study
C Imke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Share Paper
